Clene (CLNN) EBT (2020 - 2026)
Clene (CLNN) posted EBT of -$13.4 million for Q2 2026, down 45.5% on a QoQ basis from -$9.2 million in Q4 2025, and down 80.94% year-over-year from -$70.4 million in Q2 2025.
Powered by 
Analysis
Clene (CLNN) EBT (2020 - 2026) Analysis & Trends
Clene has reported EBT for 7 years, with the latest figure at -$13.4 million in Q2 2026.
- On a quarterly basis, EBT fell 80.94% year-over-year to -$13.4 million in Q2 2026; TTM through Jun 2026 was -$38.8 million, a 30.77% decrease from a year earlier, with the FY2025 full-year figure at -$26.2 million, up 33.57% from the prior year.
- EBT was -$13.4 million for Q2 2026 at Clene, down from -$9.2 million in the prior quarter.
- The five-year high for EBT was -$751000.0 in Q1 2025, with the low at -$25.1 million in Q2 2023.
- Average EBT over 5 years is -$9.3 million, with a median of -$9.2 million recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: EBT tumbled 865.18% in 2023, then jumped 93.22% in 2025.
- Over 5 years, EBT stood at -$1.1 million in 2022, then sank by 865.18% to -$10.2 million in 2023, then slumped by 33.19% to -$13.5 million in 2024, then soared by 31.91% to -$9.2 million in 2025, then plunged by 45.5% to -$13.4 million in 2026.
- The last three EBT figures came in at -$13.4 million (Q2 2026), -$9.2 million (Q4 2025), and -$8.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -653.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 1.64 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -644.37 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 751.51 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 372.70 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | -13.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.42 Mn |
| Dec 31, 2025 | -9.23 Mn |
| Sep 30, 2025 | -8.78 Mn |
| Jun 30, 2025 | -7.42 Mn |
| Mar 31, 2025 | -751,000.00 |
| Dec 31, 2024 | -13.55 Mn |
| Sep 30, 2024 | -7.99 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Mar 31, 2024 | -11.08 Mn |
| Dec 31, 2023 | -10.17 Mn |
| Sep 30, 2023 | -2.42 Mn |
| Jun 30, 2023 | -25.14 Mn |
| Mar 31, 2023 | -11.77 Mn |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | -10.98 Mn |
| Jun 30, 2022 | -4.53 Mn |
| Mar 31, 2022 | -13.35 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | 29.86 Mn |
| Jun 30, 2021 | -3.42 Mn |